BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 11157526)

  • 1. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study.
    Nielsen GL; Sørensen HT; Larsen H; Pedersen L
    BMJ; 2001 Feb; 322(7281):266-70. PubMed ID: 11157526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse pregnancy outcome in users of sulfamethizole during pregnancy: a population-based observational study.
    Ratanajamit C; Skriver MV; Nørgaard M; Jepsen P; Schønheyder HC; Sørensen HT
    J Antimicrob Chemother; 2003 Nov; 52(5):837-41. PubMed ID: 14519675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study.
    Nørgård B; Fonager K; Pedersen L; Jacobsen BA; Sørensen HT
    Gut; 2003 Feb; 52(2):243-7. PubMed ID: 12524407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse pregnancy outcome in women exposed to acyclovir during pregnancy: a population-based observational study.
    Ratanajamit C; Vinther Skriver M; Jepsen P; Chongsuvivatwong V; Olsen J; Sørensen HT
    Scand J Infect Dis; 2003; 35(4):255-9. PubMed ID: 12839155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin use and miscarriage risk.
    Keim SA; Klebanoff MA
    Epidemiology; 2006 Jul; 17(4):435-9. PubMed ID: 16755260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-obstetric abdominal surgery during pregnancy and birth outcomes: A Danish registry-based cohort study.
    Rasmussen AS; Christiansen CF; Ulrichsen SP; Uldbjerg N; Nørgaard M
    Acta Obstet Gynecol Scand; 2020 Apr; 99(4):469-476. PubMed ID: 31774546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population-based study of maternal use of amoxicillin and pregnancy outcome in Denmark.
    Jepsen P; Skriver MV; Floyd A; Lipworth L; Schønheyder HC; Sørensen HT
    Br J Clin Pharmacol; 2003 Feb; 55(2):216-21. PubMed ID: 12580995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study.
    Li DK; Liu L; Odouli R
    BMJ; 2003 Aug; 327(7411):368. PubMed ID: 12919986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taking NSAIDs during pregnancy. Is it safe?
    Jackson-Northey K; Evans MF
    Can Fam Physician; 2002 Mar; 48():483-5. PubMed ID: 11935712
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: A nested case-control study.
    Ofori B; Oraichi D; Blais L; Rey E; Bérard A
    Birth Defects Res B Dev Reprod Toxicol; 2006 Aug; 77(4):268-79. PubMed ID: 16929547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of miscarriage for pregnant users of pivmecillinam: a population-based case-control study.
    Nørgaard M; Skriver MV; Sørensen HT; Schønheyder HC; Pedersen L
    APMIS; 2008 Apr; 116(4):278-83. PubMed ID: 18397462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of miscarriage in pregnant users of NSAIDs. Miscarriages also occur in women intending to have induced abortions.
    Kristensen P
    BMJ; 2001 Jun; 322(7298):1366. PubMed ID: 11409401
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of nonsteroidal antiinflammatory drugs during pregnancy and the risk of miscarriage.
    Li DK; Ferber JR; Odouli R; Quesenberry C
    Am J Obstet Gynecol; 2018 Sep; 219(3):275.e1-275.e8. PubMed ID: 29890124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study.
    Nørgård B; Pedersen L; Christensen LA; Sørensen HT
    Am J Gastroenterol; 2007 Jul; 102(7):1406-13. PubMed ID: 17437503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydroergotamine (DHE) use during gestation and the risk of adverse pregnancy outcomes.
    Bérard A; Kori S
    Headache; 2012; 52(7):1085-93. PubMed ID: 22612391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azathioprine, mercaptopurine and birth outcome: a population-based cohort study.
    Nørgård B; Pedersen L; Fonager K; Rasmussen SN; Sørensen HT
    Aliment Pharmacol Ther; 2003 Mar; 17(6):827-34. PubMed ID: 12641505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study.
    Graner S; Svensson T; Beau AB; Damase-Michel C; Engeland A; Furu K; Hviid A; Håberg SE; Mølgaard-Nielsen D; Pasternak B; Kieler H
    BMJ; 2017 Feb; 356():j629. PubMed ID: 28246106
    [No Abstract]   [Full Text] [Related]  

  • 19. Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis.
    Rahimi R; Nikfar S; Rezaie A; Abdollahi M
    Reprod Toxicol; 2008 Feb; 25(2):271-5. PubMed ID: 18242053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipyrone use during pregnancy and adverse perinatal events.
    da Silva Dal Pizzol T; Schüler-Faccini L; Mengue SS; Fischer MI
    Arch Gynecol Obstet; 2009 Mar; 279(3):293-7. PubMed ID: 18568358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.